4.7 Review

Recent progress in the metabolic engineering of alkaloids in plant systems

期刊

CURRENT OPINION IN BIOTECHNOLOGY
卷 24, 期 2, 页码 354-365

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2012.08.003

关键词

-

资金

  1. NIH [GM074820]
  2. BBSRC [BB/J004561/1]
  3. John Innes Foundation
  4. National Science Foundation
  5. BBSRC [BB/J009091/1, BBS/E/J/000CA489] Funding Source: UKRI
  6. EPSRC [EP/J012947/1] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA489, BB/J009091/1] Funding Source: researchfish
  8. Engineering and Physical Sciences Research Council [EP/J012947/1] Funding Source: researchfish

向作者/读者索取更多资源

Plant alkaloids have a rich chemical ecology that has been exploited for medicinal purposes for thousands of years. Despite being highly represented within today's pharmacopoeia, relatively little is known about the biosynthesis, regulation and transport of these molecules.. Understanding how nature synthesizes plant alkaloids will enhance our ability to overproduce-that is, to metabolically engineer-these medicinally useful compounds as well as new-to-nature compounds (with potentially improved bioactivity) derived from these natural scaffolds. Recent progress in the metabolic engineering of nitrogen-containing plant natural products-specifically the monoterpene indole alkaloids, the benzylisoquinoline alkaloids and the glucosinolates-was made possible through the characterization of various components in both native and engineered enzymatic pathways. The subsequent reconfiguration and tuning of these biological 'parts' has enabled the production of selected products at increasingly higher titers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据